台灣生醫創新學會台灣生醫創新學會

  • 關於TiBIA
    • 成立緣起
    • 宗旨任務
    • 組織
  • 會務公告
  • 資源中心
    • 生醫最前線
    • 生醫主題館
  • 加入TiBIA
    • 加入會員
    • 與TiBIA合作
  • 聯絡TiBIA
  • 訂閱電子報
  • 細胞/基因治療
    • 每日要聞
    • 培訓課程
    • 相關會議

Global Express

Global Express
base editingT-cellsleukaemia

BBC News:Base editing: Revolutionary therapy clears girl's incurable cancer

Global Express
JAMAwastewaterSARS-CoV-2

Study: New Wastewater Surveillance Method Detected SARS-CoV-2 Variants of Concern Up to 2 Weeks Before Clinical Tests

Global Express
AINIHBridge2AI

NIH launches Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research

Global Express
ASCO

Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

Global Express
ASCOProstate Cancermolecular taxonomy

Two New Studies Find Aggressive Prostate Cancer May Be Linked to Ancestral Heritage

Global Express
AIASCOColorectal Cancerdeep learning

New Risk Stratification System for Completely Resected Stage II or III Colorectal Cancer - Implications for Adjuvant Chemotherapy

Global Express
IntradermalVaccinationMonkeypox

Intradermal Vaccination for Monkeypox — Benefits for Individual and Public Health

Global Express
FDAXenpozymeASMD

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease

Global Express

Can C. Difficile Play a Role in the Development of Colorectal Cancers?

1 2 Next page

我們是一群來自藥物開發、臨床試驗研究、精準醫學及人工智慧應用等領域的專業人士,共同建立TiBIA台灣生醫創新學會,期望為台灣生醫發展進步貢獻心力。

  • 台北市信義區松智路1號24樓
  • (02) 2732-2782 #123
  • tbia.contact2021@gmail.com
立案字號:台內團字1100041163號
|
統一編號:88236987
© 2022 All rights reserved. Web design by FT.